Citigroup’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $109K | Sell |
|
|||||
|
2025
Q2 | $220K | Sell |
|
|||||
|
2025
Q1 | $543K | Buy |
|
|||||
|
2024
Q4 | $250K | Buy |
|
|||||
|
2024
Q3 | $216K | Buy |
|
|||||
|
2024
Q2 | $34.9K | Buy |
|
|||||
|
2024
Q1 | $48K | Buy |
|
|||||
|
2023
Q4 | $40.7K | Buy |
|
|||||
|
2023
Q3 | $107 | Sell |
|
|||||
|
2023
Q2 | $65.8K | Sell |
|
|||||
|
2023
Q1 | $164K | Buy |
|
|||||
|
2022
Q4 | $34.9K | Sell |
|
|||||
|
2022
Q3 | $40K | Sell |
|
|||||
|
2022
Q2 | $1.78M | Buy |
|
|||||
|
2022
Q1 | $297K | Sell |
|
|||||
|
2021
Q4 | $1.09M | Buy |
|
|||||
|
2021
Q3 | $779K | Sell |
|
|||||
|
2021
Q2 | $2.77M | Sell |
|
|||||
|
2021
Q1 | $2.65M | Buy |
|
|||||
|
2020
Q4 | $772K | Buy |
|
|||||
|
2020
Q3 | $46K | Sell |
|
|||||
|
2020
Q2 | $118K | Sell |
|
|||||
|
2020
Q1 | $135K | Buy |
|
|||||
|
2019
Q4 | $117K | Sell |
|
|||||
|
2019
Q3 | $374K | Sell |
|
|||||
|
2019
Q2 | $533K | Buy |
|
|||||
|
2019
Q1 | $505K | Sell |
|
|||||
|
2018
Q4 | $1.8M | Buy |
|
|||||
|
2018
Q3 | $2.2M | Sell |
|
|||||
|
2018
Q2 | $2.59M | Sell |
|
|||||
|
2018
Q1 | $3.5M | Buy |
|
|||||
|
2017
Q4 | $691K | Buy |
|
|||||
|
2017
Q3 | $10K | Sell |
|
|||||
|
2017
Q2 | $18K | Sell |
|
|||||
|
2017
Q1 | $63K | Sell |
|
|||||
|
2016
Q4 | $808K | Buy |
|
|||||
|
2016
Q3 | $443K | Buy |
|
|||||
|
2016
Q2 | $45K | Sell |
|
|||||
|
2016
Q1 | $174K | Buy |
|
|||||
|
2015
Q4 | $117K | Buy |
|
|||||
|
2015
Q3 | $0 | Sell |
|
|||||
|
2015
Q2 | $5K | Sell |
|
|||||
|
2015
Q1 | $19K | Sell |
|
|||||
|
2014
Q4 | $40K | Buy |
|
|||||
|
2014
Q3 | $6K | Sell |
|
|||||
|
2014
Q2 | $37K | Sell |
|
|||||
|
2014
Q1 | $92K | Sell |
|
|||||
|
2013
Q4 | $127K | Buy |
|
|||||
|
2013
Q3 | $130K | Sell |
|
|||||
|
2013
Q2 | $140K | Buy |
|